Global Famotidine Injection Market
Global Famotidine Injection Market

Famotidine Injection Comprehensive Study by Type (Premixed Solution, Concentrated Solution), Application (Ulcers, Gastroesophageal Reflux Disease, Zollinger-Ellison Syndrome, Others), Components (L-aspartic Acid, Sodium Chloride, USP, Water), Distribution Channel (Hospital Pharmacies, Medical Stores, Online Pharmacies), Age Group (Pediatric Patients < 1 Year of Age, 1-16 Years of Age, Others), Side Effects (Headache, Hives, Rash, Dizziness, Pain, Others) Players and Region - Global Market Outlook to 2025

Famotidine Injection Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Jun 2020 Edition 227 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Famotidine Injection Market Overview:
Famotidine injection is used in people who are hospitalized to treat certain conditions in which the stomach produces too much acid, or to treat ulcers (wounds in the stomach or intestinal mucosa) that are unsuccessful with other drugs were treated. Famotidine injection is also used for a short time in people who cannot take oral medication. The injection of famotidine belongs to a class of drugs called H2 blockers. It basically works hereby reducing the amount of acid that is produced in the stomach. The famotidine injection is supplied as a solution (liquid) that is mixed with another liquid and injected intravenously (into a vein) for 2 to 30 minutes. It is also available as a pre-mixed product that can be injected intravenously over a period of 15 to 30 minutes. It is usually given every 12 hours.

Market Drivers
  • Increasing Adoption Due To Wide Range of Medical Applications of Famotidine
  • Increased Prevalence of Diseases such as Stomach Ulcers and GERD
  • Increased number of Hospitals and Clinics

Market Trend
  • Development of New Diagnostic Centres and Hospitals
  • Growing Focus on Preventive Healthcare

Restraints
  • Side Effects of the Drug

Opportunities
  • The Emergence of Developing Economies Such As India and China
  • The Growing Technological Advancements in the Famotidine
  • Increasing Awareness Regarding the Treatment
  • Growing Number of Online Pharmacies

Challenges
  • Lack of Proper Diagnosis
  • Less Awareness among the People in Developing Countries


Competitive Landscape:
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Medline Industries (United States), Allegiance Health (United States), Ciron Group (India), CVS Health (United States), Mylan N.V. (United States) and McKesson Pharma (United States). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Famotidine Injection market by 2025. Considering Market by Components, the sub-segment i.e. L-aspartic Acid will boost the Famotidine Injection market. Considering Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Famotidine Injection market. Considering Market by Age Group, the sub-segment i.e. Pediatric Patients < 1 Year of Age will boost the Famotidine Injection market. Considering Market by Side Effects, the sub-segment i.e. Headache will boost the Famotidine Injection market.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Famotidine Injection market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Famotidine Injection market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Providers of Famotidine Injection, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Premixed Solution
  • Concentrated Solution
By Application
  • Ulcers
  • Gastroesophageal Reflux Disease
  • Zollinger-Ellison Syndrome
  • Others
By Components
  • L-aspartic Acid
  • Sodium Chloride
  • USP
  • Water

By Distribution Channel
  • Hospital Pharmacies
  • Medical Stores
  • Online Pharmacies

By Age Group
  • Pediatric Patients < 1 Year of Age
  • 1-16 Years of Age
  • Others

By Side Effects
  • Headache
  • Hives
  • Rash
  • Dizziness
  • Pain
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Adoption Due To Wide Range of Medical Applications of Famotidine
      • 3.2.2. Increased Prevalence of Diseases such as Stomach Ulcers and GERD
      • 3.2.3. Increased number of Hospitals and Clinics
    • 3.3. Market Challenges
      • 3.3.1. Lack of Proper Diagnosis
      • 3.3.2. Less Awareness among the People in Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Development of New Diagnostic Centres and Hospitals
      • 3.4.2. Growing Focus on Preventive Healthcare
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Famotidine Injection, by Type, Application, Components, Distribution Channel, Age Group, Side Effects and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Famotidine Injection (Value)
      • 5.2.1. Global Famotidine Injection by: Type (Value)
        • 5.2.1.1. Premixed Solution
        • 5.2.1.2. Concentrated Solution
      • 5.2.2. Global Famotidine Injection by: Application (Value)
        • 5.2.2.1. Ulcers
        • 5.2.2.2. Gastroesophageal Reflux Disease
        • 5.2.2.3. Zollinger-Ellison Syndrome
        • 5.2.2.4. Others
      • 5.2.3. Global Famotidine Injection by: Components (Value)
        • 5.2.3.1. L-aspartic Acid
        • 5.2.3.2. Sodium Chloride
        • 5.2.3.3. USP
        • 5.2.3.4. Water
      • 5.2.4. Global Famotidine Injection by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacies
        • 5.2.4.2. Medical Stores
        • 5.2.4.3. Online Pharmacies
      • 5.2.5. Global Famotidine Injection by: Age Group (Value)
        • 5.2.5.1. Pediatric Patients < 1 Year of Age
        • 5.2.5.2. 1-16 Years of Age
        • 5.2.5.3. Others
      • 5.2.6. Global Famotidine Injection by: Side Effects (Value)
        • 5.2.6.1. Headache
        • 5.2.6.2. Hives
        • 5.2.6.3. Rash
        • 5.2.6.4. Dizziness
        • 5.2.6.5. Pain
        • 5.2.6.6. Others
      • 5.2.7. Global Famotidine Injection Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Taiwan
          • 5.2.7.2.6. Australia
          • 5.2.7.2.7. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
    • 5.3. Global Famotidine Injection (Volume)
      • 5.3.1. Global Famotidine Injection by: Type (Volume)
        • 5.3.1.1. Premixed Solution
        • 5.3.1.2. Concentrated Solution
      • 5.3.2. Global Famotidine Injection by: Application (Volume)
        • 5.3.2.1. Ulcers
        • 5.3.2.2. Gastroesophageal Reflux Disease
        • 5.3.2.3. Zollinger-Ellison Syndrome
        • 5.3.2.4. Others
      • 5.3.3. Global Famotidine Injection by: Components (Volume)
        • 5.3.3.1. L-aspartic Acid
        • 5.3.3.2. Sodium Chloride
        • 5.3.3.3. USP
        • 5.3.3.4. Water
      • 5.3.4. Global Famotidine Injection by: Distribution Channel (Volume)
        • 5.3.4.1. Hospital Pharmacies
        • 5.3.4.2. Medical Stores
        • 5.3.4.3. Online Pharmacies
      • 5.3.5. Global Famotidine Injection by: Age Group (Volume)
        • 5.3.5.1. Pediatric Patients < 1 Year of Age
        • 5.3.5.2. 1-16 Years of Age
        • 5.3.5.3. Others
      • 5.3.6. Global Famotidine Injection by: Side Effects (Volume)
        • 5.3.6.1. Headache
        • 5.3.6.2. Hives
        • 5.3.6.3. Rash
        • 5.3.6.4. Dizziness
        • 5.3.6.5. Pain
        • 5.3.6.6. Others
      • 5.3.7. Global Famotidine Injection Region
        • 5.3.7.1. South America
          • 5.3.7.1.1. Brazil
          • 5.3.7.1.2. Argentina
          • 5.3.7.1.3. Rest of South America
        • 5.3.7.2. Asia Pacific
          • 5.3.7.2.1. China
          • 5.3.7.2.2. Japan
          • 5.3.7.2.3. India
          • 5.3.7.2.4. South Korea
          • 5.3.7.2.5. Taiwan
          • 5.3.7.2.6. Australia
          • 5.3.7.2.7. Rest of Asia-Pacific
        • 5.3.7.3. Europe
          • 5.3.7.3.1. Germany
          • 5.3.7.3.2. France
          • 5.3.7.3.3. Italy
          • 5.3.7.3.4. United Kingdom
          • 5.3.7.3.5. Netherlands
          • 5.3.7.3.6. Rest of Europe
        • 5.3.7.4. MEA
          • 5.3.7.4.1. Middle East
          • 5.3.7.4.2. Africa
        • 5.3.7.5. North America
          • 5.3.7.5.1. United States
          • 5.3.7.5.2. Canada
          • 5.3.7.5.3. Mexico
    • 5.4. Global Famotidine Injection (Price)
      • 5.4.1. Global Famotidine Injection by: Type (Price)
  • 6. Famotidine Injection: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medline Industries (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Allegiance Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ciron Group (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CVS Health (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Mylan N.V. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. McKesson Pharma (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Famotidine Injection Sale, by Type, Application, Components, Distribution Channel, Age Group, Side Effects and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Famotidine Injection (Value)
      • 7.2.1. Global Famotidine Injection by: Type (Value)
        • 7.2.1.1. Premixed Solution
        • 7.2.1.2. Concentrated Solution
      • 7.2.2. Global Famotidine Injection by: Application (Value)
        • 7.2.2.1. Ulcers
        • 7.2.2.2. Gastroesophageal Reflux Disease
        • 7.2.2.3. Zollinger-Ellison Syndrome
        • 7.2.2.4. Others
      • 7.2.3. Global Famotidine Injection by: Components (Value)
        • 7.2.3.1. L-aspartic Acid
        • 7.2.3.2. Sodium Chloride
        • 7.2.3.3. USP
        • 7.2.3.4. Water
      • 7.2.4. Global Famotidine Injection by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacies
        • 7.2.4.2. Medical Stores
        • 7.2.4.3. Online Pharmacies
      • 7.2.5. Global Famotidine Injection by: Age Group (Value)
        • 7.2.5.1. Pediatric Patients < 1 Year of Age
        • 7.2.5.2. 1-16 Years of Age
        • 7.2.5.3. Others
      • 7.2.6. Global Famotidine Injection by: Side Effects (Value)
        • 7.2.6.1. Headache
        • 7.2.6.2. Hives
        • 7.2.6.3. Rash
        • 7.2.6.4. Dizziness
        • 7.2.6.5. Pain
        • 7.2.6.6. Others
      • 7.2.7. Global Famotidine Injection Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Taiwan
          • 7.2.7.2.6. Australia
          • 7.2.7.2.7. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
    • 7.3. Global Famotidine Injection (Volume)
      • 7.3.1. Global Famotidine Injection by: Type (Volume)
        • 7.3.1.1. Premixed Solution
        • 7.3.1.2. Concentrated Solution
      • 7.3.2. Global Famotidine Injection by: Application (Volume)
        • 7.3.2.1. Ulcers
        • 7.3.2.2. Gastroesophageal Reflux Disease
        • 7.3.2.3. Zollinger-Ellison Syndrome
        • 7.3.2.4. Others
      • 7.3.3. Global Famotidine Injection by: Components (Volume)
        • 7.3.3.1. L-aspartic Acid
        • 7.3.3.2. Sodium Chloride
        • 7.3.3.3. USP
        • 7.3.3.4. Water
      • 7.3.4. Global Famotidine Injection by: Distribution Channel (Volume)
        • 7.3.4.1. Hospital Pharmacies
        • 7.3.4.2. Medical Stores
        • 7.3.4.3. Online Pharmacies
      • 7.3.5. Global Famotidine Injection by: Age Group (Volume)
        • 7.3.5.1. Pediatric Patients < 1 Year of Age
        • 7.3.5.2. 1-16 Years of Age
        • 7.3.5.3. Others
      • 7.3.6. Global Famotidine Injection by: Side Effects (Volume)
        • 7.3.6.1. Headache
        • 7.3.6.2. Hives
        • 7.3.6.3. Rash
        • 7.3.6.4. Dizziness
        • 7.3.6.5. Pain
        • 7.3.6.6. Others
      • 7.3.7. Global Famotidine Injection Region
        • 7.3.7.1. South America
          • 7.3.7.1.1. Brazil
          • 7.3.7.1.2. Argentina
          • 7.3.7.1.3. Rest of South America
        • 7.3.7.2. Asia Pacific
          • 7.3.7.2.1. China
          • 7.3.7.2.2. Japan
          • 7.3.7.2.3. India
          • 7.3.7.2.4. South Korea
          • 7.3.7.2.5. Taiwan
          • 7.3.7.2.6. Australia
          • 7.3.7.2.7. Rest of Asia-Pacific
        • 7.3.7.3. Europe
          • 7.3.7.3.1. Germany
          • 7.3.7.3.2. France
          • 7.3.7.3.3. Italy
          • 7.3.7.3.4. United Kingdom
          • 7.3.7.3.5. Netherlands
          • 7.3.7.3.6. Rest of Europe
        • 7.3.7.4. MEA
          • 7.3.7.4.1. Middle East
          • 7.3.7.4.2. Africa
        • 7.3.7.5. North America
          • 7.3.7.5.1. United States
          • 7.3.7.5.2. Canada
          • 7.3.7.5.3. Mexico
    • 7.4. Global Famotidine Injection (Price)
      • 7.4.1. Global Famotidine Injection by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Famotidine Injection: by Type(USD Million)
  • Table 2. Famotidine Injection Premixed Solution , by Region USD Million (2014-2019)
  • Table 3. Famotidine Injection Concentrated Solution , by Region USD Million (2014-2019)
  • Table 4. Famotidine Injection: by Application(USD Million)
  • Table 5. Famotidine Injection Ulcers , by Region USD Million (2014-2019)
  • Table 6. Famotidine Injection Gastroesophageal Reflux Disease , by Region USD Million (2014-2019)
  • Table 7. Famotidine Injection Zollinger-Ellison Syndrome , by Region USD Million (2014-2019)
  • Table 8. Famotidine Injection Others , by Region USD Million (2014-2019)
  • Table 9. Famotidine Injection: by Components(USD Million)
  • Table 10. Famotidine Injection L-aspartic Acid , by Region USD Million (2014-2019)
  • Table 11. Famotidine Injection Sodium Chloride , by Region USD Million (2014-2019)
  • Table 12. Famotidine Injection USP , by Region USD Million (2014-2019)
  • Table 13. Famotidine Injection Water , by Region USD Million (2014-2019)
  • Table 14. Famotidine Injection: by Distribution Channel(USD Million)
  • Table 15. Famotidine Injection Hospital Pharmacies , by Region USD Million (2014-2019)
  • Table 16. Famotidine Injection Medical Stores , by Region USD Million (2014-2019)
  • Table 17. Famotidine Injection Online Pharmacies , by Region USD Million (2014-2019)
  • Table 18. Famotidine Injection: by Age Group(USD Million)
  • Table 19. Famotidine Injection Pediatric Patients < 1 Year of Age , by Region USD Million (2014-2019)
  • Table 20. Famotidine Injection 1-16 Years of Age , by Region USD Million (2014-2019)
  • Table 21. Famotidine Injection Others , by Region USD Million (2014-2019)
  • Table 22. Famotidine Injection: by Side Effects(USD Million)
  • Table 23. Famotidine Injection Headache , by Region USD Million (2014-2019)
  • Table 24. Famotidine Injection Hives , by Region USD Million (2014-2019)
  • Table 25. Famotidine Injection Rash , by Region USD Million (2014-2019)
  • Table 26. Famotidine Injection Dizziness , by Region USD Million (2014-2019)
  • Table 27. Famotidine Injection Pain , by Region USD Million (2014-2019)
  • Table 28. Famotidine Injection Others , by Region USD Million (2014-2019)
  • Table 29. South America Famotidine Injection, by Country USD Million (2014-2019)
  • Table 30. South America Famotidine Injection, by Type USD Million (2014-2019)
  • Table 31. South America Famotidine Injection, by Application USD Million (2014-2019)
  • Table 32. South America Famotidine Injection, by Components USD Million (2014-2019)
  • Table 33. South America Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 34. South America Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 35. South America Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 36. Brazil Famotidine Injection, by Type USD Million (2014-2019)
  • Table 37. Brazil Famotidine Injection, by Application USD Million (2014-2019)
  • Table 38. Brazil Famotidine Injection, by Components USD Million (2014-2019)
  • Table 39. Brazil Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 40. Brazil Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 41. Brazil Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 42. Argentina Famotidine Injection, by Type USD Million (2014-2019)
  • Table 43. Argentina Famotidine Injection, by Application USD Million (2014-2019)
  • Table 44. Argentina Famotidine Injection, by Components USD Million (2014-2019)
  • Table 45. Argentina Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 46. Argentina Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 47. Argentina Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 48. Rest of South America Famotidine Injection, by Type USD Million (2014-2019)
  • Table 49. Rest of South America Famotidine Injection, by Application USD Million (2014-2019)
  • Table 50. Rest of South America Famotidine Injection, by Components USD Million (2014-2019)
  • Table 51. Rest of South America Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 52. Rest of South America Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 53. Rest of South America Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 54. Asia Pacific Famotidine Injection, by Country USD Million (2014-2019)
  • Table 55. Asia Pacific Famotidine Injection, by Type USD Million (2014-2019)
  • Table 56. Asia Pacific Famotidine Injection, by Application USD Million (2014-2019)
  • Table 57. Asia Pacific Famotidine Injection, by Components USD Million (2014-2019)
  • Table 58. Asia Pacific Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 59. Asia Pacific Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 60. Asia Pacific Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 61. China Famotidine Injection, by Type USD Million (2014-2019)
  • Table 62. China Famotidine Injection, by Application USD Million (2014-2019)
  • Table 63. China Famotidine Injection, by Components USD Million (2014-2019)
  • Table 64. China Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 65. China Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 66. China Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 67. Japan Famotidine Injection, by Type USD Million (2014-2019)
  • Table 68. Japan Famotidine Injection, by Application USD Million (2014-2019)
  • Table 69. Japan Famotidine Injection, by Components USD Million (2014-2019)
  • Table 70. Japan Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 71. Japan Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 72. Japan Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 73. India Famotidine Injection, by Type USD Million (2014-2019)
  • Table 74. India Famotidine Injection, by Application USD Million (2014-2019)
  • Table 75. India Famotidine Injection, by Components USD Million (2014-2019)
  • Table 76. India Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 77. India Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 78. India Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 79. South Korea Famotidine Injection, by Type USD Million (2014-2019)
  • Table 80. South Korea Famotidine Injection, by Application USD Million (2014-2019)
  • Table 81. South Korea Famotidine Injection, by Components USD Million (2014-2019)
  • Table 82. South Korea Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 83. South Korea Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 84. South Korea Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 85. Taiwan Famotidine Injection, by Type USD Million (2014-2019)
  • Table 86. Taiwan Famotidine Injection, by Application USD Million (2014-2019)
  • Table 87. Taiwan Famotidine Injection, by Components USD Million (2014-2019)
  • Table 88. Taiwan Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 89. Taiwan Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 90. Taiwan Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 91. Australia Famotidine Injection, by Type USD Million (2014-2019)
  • Table 92. Australia Famotidine Injection, by Application USD Million (2014-2019)
  • Table 93. Australia Famotidine Injection, by Components USD Million (2014-2019)
  • Table 94. Australia Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 95. Australia Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 96. Australia Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 97. Rest of Asia-Pacific Famotidine Injection, by Type USD Million (2014-2019)
  • Table 98. Rest of Asia-Pacific Famotidine Injection, by Application USD Million (2014-2019)
  • Table 99. Rest of Asia-Pacific Famotidine Injection, by Components USD Million (2014-2019)
  • Table 100. Rest of Asia-Pacific Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 101. Rest of Asia-Pacific Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 102. Rest of Asia-Pacific Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 103. Europe Famotidine Injection, by Country USD Million (2014-2019)
  • Table 104. Europe Famotidine Injection, by Type USD Million (2014-2019)
  • Table 105. Europe Famotidine Injection, by Application USD Million (2014-2019)
  • Table 106. Europe Famotidine Injection, by Components USD Million (2014-2019)
  • Table 107. Europe Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 108. Europe Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 109. Europe Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 110. Germany Famotidine Injection, by Type USD Million (2014-2019)
  • Table 111. Germany Famotidine Injection, by Application USD Million (2014-2019)
  • Table 112. Germany Famotidine Injection, by Components USD Million (2014-2019)
  • Table 113. Germany Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 114. Germany Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 115. Germany Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 116. France Famotidine Injection, by Type USD Million (2014-2019)
  • Table 117. France Famotidine Injection, by Application USD Million (2014-2019)
  • Table 118. France Famotidine Injection, by Components USD Million (2014-2019)
  • Table 119. France Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 120. France Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 121. France Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 122. Italy Famotidine Injection, by Type USD Million (2014-2019)
  • Table 123. Italy Famotidine Injection, by Application USD Million (2014-2019)
  • Table 124. Italy Famotidine Injection, by Components USD Million (2014-2019)
  • Table 125. Italy Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 126. Italy Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 127. Italy Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 128. United Kingdom Famotidine Injection, by Type USD Million (2014-2019)
  • Table 129. United Kingdom Famotidine Injection, by Application USD Million (2014-2019)
  • Table 130. United Kingdom Famotidine Injection, by Components USD Million (2014-2019)
  • Table 131. United Kingdom Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 132. United Kingdom Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 133. United Kingdom Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 134. Netherlands Famotidine Injection, by Type USD Million (2014-2019)
  • Table 135. Netherlands Famotidine Injection, by Application USD Million (2014-2019)
  • Table 136. Netherlands Famotidine Injection, by Components USD Million (2014-2019)
  • Table 137. Netherlands Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 138. Netherlands Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 139. Netherlands Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 140. Rest of Europe Famotidine Injection, by Type USD Million (2014-2019)
  • Table 141. Rest of Europe Famotidine Injection, by Application USD Million (2014-2019)
  • Table 142. Rest of Europe Famotidine Injection, by Components USD Million (2014-2019)
  • Table 143. Rest of Europe Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 144. Rest of Europe Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 145. Rest of Europe Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 146. MEA Famotidine Injection, by Country USD Million (2014-2019)
  • Table 147. MEA Famotidine Injection, by Type USD Million (2014-2019)
  • Table 148. MEA Famotidine Injection, by Application USD Million (2014-2019)
  • Table 149. MEA Famotidine Injection, by Components USD Million (2014-2019)
  • Table 150. MEA Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 151. MEA Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 152. MEA Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 153. Middle East Famotidine Injection, by Type USD Million (2014-2019)
  • Table 154. Middle East Famotidine Injection, by Application USD Million (2014-2019)
  • Table 155. Middle East Famotidine Injection, by Components USD Million (2014-2019)
  • Table 156. Middle East Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 157. Middle East Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 158. Middle East Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 159. Africa Famotidine Injection, by Type USD Million (2014-2019)
  • Table 160. Africa Famotidine Injection, by Application USD Million (2014-2019)
  • Table 161. Africa Famotidine Injection, by Components USD Million (2014-2019)
  • Table 162. Africa Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 163. Africa Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 164. Africa Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 165. North America Famotidine Injection, by Country USD Million (2014-2019)
  • Table 166. North America Famotidine Injection, by Type USD Million (2014-2019)
  • Table 167. North America Famotidine Injection, by Application USD Million (2014-2019)
  • Table 168. North America Famotidine Injection, by Components USD Million (2014-2019)
  • Table 169. North America Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 170. North America Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 171. North America Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 172. United States Famotidine Injection, by Type USD Million (2014-2019)
  • Table 173. United States Famotidine Injection, by Application USD Million (2014-2019)
  • Table 174. United States Famotidine Injection, by Components USD Million (2014-2019)
  • Table 175. United States Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 176. United States Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 177. United States Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 178. Canada Famotidine Injection, by Type USD Million (2014-2019)
  • Table 179. Canada Famotidine Injection, by Application USD Million (2014-2019)
  • Table 180. Canada Famotidine Injection, by Components USD Million (2014-2019)
  • Table 181. Canada Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 182. Canada Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 183. Canada Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 184. Mexico Famotidine Injection, by Type USD Million (2014-2019)
  • Table 185. Mexico Famotidine Injection, by Application USD Million (2014-2019)
  • Table 186. Mexico Famotidine Injection, by Components USD Million (2014-2019)
  • Table 187. Mexico Famotidine Injection, by Distribution Channel USD Million (2014-2019)
  • Table 188. Mexico Famotidine Injection, by Age Group USD Million (2014-2019)
  • Table 189. Mexico Famotidine Injection, by Side Effects USD Million (2014-2019)
  • Table 190. Famotidine Injection Sales: by Type(K Tons)
  • Table 191. Famotidine Injection Sales Premixed Solution , by Region K Tons (2014-2019)
  • Table 192. Famotidine Injection Sales Concentrated Solution , by Region K Tons (2014-2019)
  • Table 193. Famotidine Injection Sales: by Application(K Tons)
  • Table 194. Famotidine Injection Sales Ulcers , by Region K Tons (2014-2019)
  • Table 195. Famotidine Injection Sales Gastroesophageal Reflux Disease , by Region K Tons (2014-2019)
  • Table 196. Famotidine Injection Sales Zollinger-Ellison Syndrome , by Region K Tons (2014-2019)
  • Table 197. Famotidine Injection Sales Others , by Region K Tons (2014-2019)
  • Table 198. Famotidine Injection Sales: by Components(K Tons)
  • Table 199. Famotidine Injection Sales L-aspartic Acid , by Region K Tons (2014-2019)
  • Table 200. Famotidine Injection Sales Sodium Chloride , by Region K Tons (2014-2019)
  • Table 201. Famotidine Injection Sales USP , by Region K Tons (2014-2019)
  • Table 202. Famotidine Injection Sales Water , by Region K Tons (2014-2019)
  • Table 203. Famotidine Injection Sales: by Distribution Channel(K Tons)
  • Table 204. Famotidine Injection Sales Hospital Pharmacies , by Region K Tons (2014-2019)
  • Table 205. Famotidine Injection Sales Medical Stores , by Region K Tons (2014-2019)
  • Table 206. Famotidine Injection Sales Online Pharmacies , by Region K Tons (2014-2019)
  • Table 207. Famotidine Injection Sales: by Age Group(K Tons)
  • Table 208. Famotidine Injection Sales Pediatric Patients < 1 Year of Age , by Region K Tons (2014-2019)
  • Table 209. Famotidine Injection Sales 1-16 Years of Age , by Region K Tons (2014-2019)
  • Table 210. Famotidine Injection Sales Others , by Region K Tons (2014-2019)
  • Table 211. Famotidine Injection Sales: by Side Effects(K Tons)
  • Table 212. Famotidine Injection Sales Headache , by Region K Tons (2014-2019)
  • Table 213. Famotidine Injection Sales Hives , by Region K Tons (2014-2019)
  • Table 214. Famotidine Injection Sales Rash , by Region K Tons (2014-2019)
  • Table 215. Famotidine Injection Sales Dizziness , by Region K Tons (2014-2019)
  • Table 216. Famotidine Injection Sales Pain , by Region K Tons (2014-2019)
  • Table 217. Famotidine Injection Sales Others , by Region K Tons (2014-2019)
  • Table 218. South America Famotidine Injection Sales, by Country K Tons (2014-2019)
  • Table 219. South America Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 220. South America Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 221. South America Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 222. South America Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 223. South America Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 224. South America Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 225. Brazil Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 226. Brazil Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 227. Brazil Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 228. Brazil Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 229. Brazil Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 230. Brazil Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 231. Argentina Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 232. Argentina Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 233. Argentina Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 234. Argentina Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 235. Argentina Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 236. Argentina Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 237. Rest of South America Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 238. Rest of South America Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 239. Rest of South America Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 240. Rest of South America Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 241. Rest of South America Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 242. Rest of South America Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 243. Asia Pacific Famotidine Injection Sales, by Country K Tons (2014-2019)
  • Table 244. Asia Pacific Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 245. Asia Pacific Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 246. Asia Pacific Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 247. Asia Pacific Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 248. Asia Pacific Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 249. Asia Pacific Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 250. China Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 251. China Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 252. China Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 253. China Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 254. China Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 255. China Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 256. Japan Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 257. Japan Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 258. Japan Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 259. Japan Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 260. Japan Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 261. Japan Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 262. India Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 263. India Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 264. India Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 265. India Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 266. India Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 267. India Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 268. South Korea Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 269. South Korea Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 270. South Korea Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 271. South Korea Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 272. South Korea Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 273. South Korea Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 274. Taiwan Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 275. Taiwan Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 276. Taiwan Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 277. Taiwan Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 278. Taiwan Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 279. Taiwan Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 280. Australia Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 281. Australia Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 282. Australia Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 283. Australia Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 284. Australia Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 285. Australia Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 286. Rest of Asia-Pacific Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 287. Rest of Asia-Pacific Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 288. Rest of Asia-Pacific Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 289. Rest of Asia-Pacific Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 290. Rest of Asia-Pacific Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 291. Rest of Asia-Pacific Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 292. Europe Famotidine Injection Sales, by Country K Tons (2014-2019)
  • Table 293. Europe Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 294. Europe Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 295. Europe Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 296. Europe Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 297. Europe Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 298. Europe Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 299. Germany Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 300. Germany Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 301. Germany Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 302. Germany Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 303. Germany Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 304. Germany Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 305. France Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 306. France Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 307. France Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 308. France Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 309. France Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 310. France Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 311. Italy Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 312. Italy Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 313. Italy Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 314. Italy Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 315. Italy Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 316. Italy Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 317. United Kingdom Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 318. United Kingdom Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 319. United Kingdom Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 320. United Kingdom Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 321. United Kingdom Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 322. United Kingdom Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 323. Netherlands Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 324. Netherlands Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 325. Netherlands Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 326. Netherlands Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 327. Netherlands Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 328. Netherlands Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 329. Rest of Europe Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 330. Rest of Europe Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 331. Rest of Europe Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 332. Rest of Europe Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 333. Rest of Europe Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 334. Rest of Europe Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 335. MEA Famotidine Injection Sales, by Country K Tons (2014-2019)
  • Table 336. MEA Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 337. MEA Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 338. MEA Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 339. MEA Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 340. MEA Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 341. MEA Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 342. Middle East Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 343. Middle East Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 344. Middle East Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 345. Middle East Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 346. Middle East Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 347. Middle East Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 348. Africa Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 349. Africa Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 350. Africa Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 351. Africa Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 352. Africa Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 353. Africa Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 354. North America Famotidine Injection Sales, by Country K Tons (2014-2019)
  • Table 355. North America Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 356. North America Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 357. North America Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 358. North America Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 359. North America Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 360. North America Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 361. United States Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 362. United States Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 363. United States Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 364. United States Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 365. United States Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 366. United States Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 367. Canada Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 368. Canada Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 369. Canada Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 370. Canada Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 371. Canada Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 372. Canada Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 373. Mexico Famotidine Injection Sales, by Type K Tons (2014-2019)
  • Table 374. Mexico Famotidine Injection Sales, by Application K Tons (2014-2019)
  • Table 375. Mexico Famotidine Injection Sales, by Components K Tons (2014-2019)
  • Table 376. Mexico Famotidine Injection Sales, by Distribution Channel K Tons (2014-2019)
  • Table 377. Mexico Famotidine Injection Sales, by Age Group K Tons (2014-2019)
  • Table 378. Mexico Famotidine Injection Sales, by Side Effects K Tons (2014-2019)
  • Table 379. Famotidine Injection: by Type(USD/Units)
  • Table 380. Company Basic Information, Sales Area and Its Competitors
  • Table 381. Company Basic Information, Sales Area and Its Competitors
  • Table 382. Company Basic Information, Sales Area and Its Competitors
  • Table 383. Company Basic Information, Sales Area and Its Competitors
  • Table 384. Company Basic Information, Sales Area and Its Competitors
  • Table 385. Company Basic Information, Sales Area and Its Competitors
  • Table 386. Famotidine Injection: by Type(USD Million)
  • Table 387. Famotidine Injection Premixed Solution , by Region USD Million (2020-2025)
  • Table 388. Famotidine Injection Concentrated Solution , by Region USD Million (2020-2025)
  • Table 389. Famotidine Injection: by Application(USD Million)
  • Table 390. Famotidine Injection Ulcers , by Region USD Million (2020-2025)
  • Table 391. Famotidine Injection Gastroesophageal Reflux Disease , by Region USD Million (2020-2025)
  • Table 392. Famotidine Injection Zollinger-Ellison Syndrome , by Region USD Million (2020-2025)
  • Table 393. Famotidine Injection Others , by Region USD Million (2020-2025)
  • Table 394. Famotidine Injection: by Components(USD Million)
  • Table 395. Famotidine Injection L-aspartic Acid , by Region USD Million (2020-2025)
  • Table 396. Famotidine Injection Sodium Chloride , by Region USD Million (2020-2025)
  • Table 397. Famotidine Injection USP , by Region USD Million (2020-2025)
  • Table 398. Famotidine Injection Water , by Region USD Million (2020-2025)
  • Table 399. Famotidine Injection: by Distribution Channel(USD Million)
  • Table 400. Famotidine Injection Hospital Pharmacies , by Region USD Million (2020-2025)
  • Table 401. Famotidine Injection Medical Stores , by Region USD Million (2020-2025)
  • Table 402. Famotidine Injection Online Pharmacies , by Region USD Million (2020-2025)
  • Table 403. Famotidine Injection: by Age Group(USD Million)
  • Table 404. Famotidine Injection Pediatric Patients < 1 Year of Age , by Region USD Million (2020-2025)
  • Table 405. Famotidine Injection 1-16 Years of Age , by Region USD Million (2020-2025)
  • Table 406. Famotidine Injection Others , by Region USD Million (2020-2025)
  • Table 407. Famotidine Injection: by Side Effects(USD Million)
  • Table 408. Famotidine Injection Headache , by Region USD Million (2020-2025)
  • Table 409. Famotidine Injection Hives , by Region USD Million (2020-2025)
  • Table 410. Famotidine Injection Rash , by Region USD Million (2020-2025)
  • Table 411. Famotidine Injection Dizziness , by Region USD Million (2020-2025)
  • Table 412. Famotidine Injection Pain , by Region USD Million (2020-2025)
  • Table 413. Famotidine Injection Others , by Region USD Million (2020-2025)
  • Table 414. South America Famotidine Injection, by Country USD Million (2020-2025)
  • Table 415. South America Famotidine Injection, by Type USD Million (2020-2025)
  • Table 416. South America Famotidine Injection, by Application USD Million (2020-2025)
  • Table 417. South America Famotidine Injection, by Components USD Million (2020-2025)
  • Table 418. South America Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 419. South America Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 420. South America Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 421. Brazil Famotidine Injection, by Type USD Million (2020-2025)
  • Table 422. Brazil Famotidine Injection, by Application USD Million (2020-2025)
  • Table 423. Brazil Famotidine Injection, by Components USD Million (2020-2025)
  • Table 424. Brazil Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 425. Brazil Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 426. Brazil Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 427. Argentina Famotidine Injection, by Type USD Million (2020-2025)
  • Table 428. Argentina Famotidine Injection, by Application USD Million (2020-2025)
  • Table 429. Argentina Famotidine Injection, by Components USD Million (2020-2025)
  • Table 430. Argentina Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 431. Argentina Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 432. Argentina Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 433. Rest of South America Famotidine Injection, by Type USD Million (2020-2025)
  • Table 434. Rest of South America Famotidine Injection, by Application USD Million (2020-2025)
  • Table 435. Rest of South America Famotidine Injection, by Components USD Million (2020-2025)
  • Table 436. Rest of South America Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 437. Rest of South America Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 438. Rest of South America Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 439. Asia Pacific Famotidine Injection, by Country USD Million (2020-2025)
  • Table 440. Asia Pacific Famotidine Injection, by Type USD Million (2020-2025)
  • Table 441. Asia Pacific Famotidine Injection, by Application USD Million (2020-2025)
  • Table 442. Asia Pacific Famotidine Injection, by Components USD Million (2020-2025)
  • Table 443. Asia Pacific Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 444. Asia Pacific Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 445. Asia Pacific Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 446. China Famotidine Injection, by Type USD Million (2020-2025)
  • Table 447. China Famotidine Injection, by Application USD Million (2020-2025)
  • Table 448. China Famotidine Injection, by Components USD Million (2020-2025)
  • Table 449. China Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 450. China Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 451. China Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 452. Japan Famotidine Injection, by Type USD Million (2020-2025)
  • Table 453. Japan Famotidine Injection, by Application USD Million (2020-2025)
  • Table 454. Japan Famotidine Injection, by Components USD Million (2020-2025)
  • Table 455. Japan Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 456. Japan Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 457. Japan Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 458. India Famotidine Injection, by Type USD Million (2020-2025)
  • Table 459. India Famotidine Injection, by Application USD Million (2020-2025)
  • Table 460. India Famotidine Injection, by Components USD Million (2020-2025)
  • Table 461. India Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 462. India Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 463. India Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 464. South Korea Famotidine Injection, by Type USD Million (2020-2025)
  • Table 465. South Korea Famotidine Injection, by Application USD Million (2020-2025)
  • Table 466. South Korea Famotidine Injection, by Components USD Million (2020-2025)
  • Table 467. South Korea Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 468. South Korea Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 469. South Korea Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 470. Taiwan Famotidine Injection, by Type USD Million (2020-2025)
  • Table 471. Taiwan Famotidine Injection, by Application USD Million (2020-2025)
  • Table 472. Taiwan Famotidine Injection, by Components USD Million (2020-2025)
  • Table 473. Taiwan Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 474. Taiwan Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 475. Taiwan Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 476. Australia Famotidine Injection, by Type USD Million (2020-2025)
  • Table 477. Australia Famotidine Injection, by Application USD Million (2020-2025)
  • Table 478. Australia Famotidine Injection, by Components USD Million (2020-2025)
  • Table 479. Australia Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 480. Australia Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 481. Australia Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 482. Rest of Asia-Pacific Famotidine Injection, by Type USD Million (2020-2025)
  • Table 483. Rest of Asia-Pacific Famotidine Injection, by Application USD Million (2020-2025)
  • Table 484. Rest of Asia-Pacific Famotidine Injection, by Components USD Million (2020-2025)
  • Table 485. Rest of Asia-Pacific Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 486. Rest of Asia-Pacific Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 487. Rest of Asia-Pacific Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 488. Europe Famotidine Injection, by Country USD Million (2020-2025)
  • Table 489. Europe Famotidine Injection, by Type USD Million (2020-2025)
  • Table 490. Europe Famotidine Injection, by Application USD Million (2020-2025)
  • Table 491. Europe Famotidine Injection, by Components USD Million (2020-2025)
  • Table 492. Europe Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 493. Europe Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 494. Europe Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 495. Germany Famotidine Injection, by Type USD Million (2020-2025)
  • Table 496. Germany Famotidine Injection, by Application USD Million (2020-2025)
  • Table 497. Germany Famotidine Injection, by Components USD Million (2020-2025)
  • Table 498. Germany Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 499. Germany Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 500. Germany Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 501. France Famotidine Injection, by Type USD Million (2020-2025)
  • Table 502. France Famotidine Injection, by Application USD Million (2020-2025)
  • Table 503. France Famotidine Injection, by Components USD Million (2020-2025)
  • Table 504. France Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 505. France Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 506. France Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 507. Italy Famotidine Injection, by Type USD Million (2020-2025)
  • Table 508. Italy Famotidine Injection, by Application USD Million (2020-2025)
  • Table 509. Italy Famotidine Injection, by Components USD Million (2020-2025)
  • Table 510. Italy Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 511. Italy Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 512. Italy Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 513. United Kingdom Famotidine Injection, by Type USD Million (2020-2025)
  • Table 514. United Kingdom Famotidine Injection, by Application USD Million (2020-2025)
  • Table 515. United Kingdom Famotidine Injection, by Components USD Million (2020-2025)
  • Table 516. United Kingdom Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 517. United Kingdom Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 518. United Kingdom Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 519. Netherlands Famotidine Injection, by Type USD Million (2020-2025)
  • Table 520. Netherlands Famotidine Injection, by Application USD Million (2020-2025)
  • Table 521. Netherlands Famotidine Injection, by Components USD Million (2020-2025)
  • Table 522. Netherlands Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 523. Netherlands Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 524. Netherlands Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 525. Rest of Europe Famotidine Injection, by Type USD Million (2020-2025)
  • Table 526. Rest of Europe Famotidine Injection, by Application USD Million (2020-2025)
  • Table 527. Rest of Europe Famotidine Injection, by Components USD Million (2020-2025)
  • Table 528. Rest of Europe Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 529. Rest of Europe Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 530. Rest of Europe Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 531. MEA Famotidine Injection, by Country USD Million (2020-2025)
  • Table 532. MEA Famotidine Injection, by Type USD Million (2020-2025)
  • Table 533. MEA Famotidine Injection, by Application USD Million (2020-2025)
  • Table 534. MEA Famotidine Injection, by Components USD Million (2020-2025)
  • Table 535. MEA Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 536. MEA Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 537. MEA Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 538. Middle East Famotidine Injection, by Type USD Million (2020-2025)
  • Table 539. Middle East Famotidine Injection, by Application USD Million (2020-2025)
  • Table 540. Middle East Famotidine Injection, by Components USD Million (2020-2025)
  • Table 541. Middle East Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 542. Middle East Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 543. Middle East Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 544. Africa Famotidine Injection, by Type USD Million (2020-2025)
  • Table 545. Africa Famotidine Injection, by Application USD Million (2020-2025)
  • Table 546. Africa Famotidine Injection, by Components USD Million (2020-2025)
  • Table 547. Africa Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 548. Africa Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 549. Africa Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 550. North America Famotidine Injection, by Country USD Million (2020-2025)
  • Table 551. North America Famotidine Injection, by Type USD Million (2020-2025)
  • Table 552. North America Famotidine Injection, by Application USD Million (2020-2025)
  • Table 553. North America Famotidine Injection, by Components USD Million (2020-2025)
  • Table 554. North America Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 555. North America Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 556. North America Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 557. United States Famotidine Injection, by Type USD Million (2020-2025)
  • Table 558. United States Famotidine Injection, by Application USD Million (2020-2025)
  • Table 559. United States Famotidine Injection, by Components USD Million (2020-2025)
  • Table 560. United States Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 561. United States Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 562. United States Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 563. Canada Famotidine Injection, by Type USD Million (2020-2025)
  • Table 564. Canada Famotidine Injection, by Application USD Million (2020-2025)
  • Table 565. Canada Famotidine Injection, by Components USD Million (2020-2025)
  • Table 566. Canada Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 567. Canada Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 568. Canada Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 569. Mexico Famotidine Injection, by Type USD Million (2020-2025)
  • Table 570. Mexico Famotidine Injection, by Application USD Million (2020-2025)
  • Table 571. Mexico Famotidine Injection, by Components USD Million (2020-2025)
  • Table 572. Mexico Famotidine Injection, by Distribution Channel USD Million (2020-2025)
  • Table 573. Mexico Famotidine Injection, by Age Group USD Million (2020-2025)
  • Table 574. Mexico Famotidine Injection, by Side Effects USD Million (2020-2025)
  • Table 575. Famotidine Injection Sales: by Type(K Tons)
  • Table 576. Famotidine Injection Sales Premixed Solution , by Region K Tons (2020-2025)
  • Table 577. Famotidine Injection Sales Concentrated Solution , by Region K Tons (2020-2025)
  • Table 578. Famotidine Injection Sales: by Application(K Tons)
  • Table 579. Famotidine Injection Sales Ulcers , by Region K Tons (2020-2025)
  • Table 580. Famotidine Injection Sales Gastroesophageal Reflux Disease , by Region K Tons (2020-2025)
  • Table 581. Famotidine Injection Sales Zollinger-Ellison Syndrome , by Region K Tons (2020-2025)
  • Table 582. Famotidine Injection Sales Others , by Region K Tons (2020-2025)
  • Table 583. Famotidine Injection Sales: by Components(K Tons)
  • Table 584. Famotidine Injection Sales L-aspartic Acid , by Region K Tons (2020-2025)
  • Table 585. Famotidine Injection Sales Sodium Chloride , by Region K Tons (2020-2025)
  • Table 586. Famotidine Injection Sales USP , by Region K Tons (2020-2025)
  • Table 587. Famotidine Injection Sales Water , by Region K Tons (2020-2025)
  • Table 588. Famotidine Injection Sales: by Distribution Channel(K Tons)
  • Table 589. Famotidine Injection Sales Hospital Pharmacies , by Region K Tons (2020-2025)
  • Table 590. Famotidine Injection Sales Medical Stores , by Region K Tons (2020-2025)
  • Table 591. Famotidine Injection Sales Online Pharmacies , by Region K Tons (2020-2025)
  • Table 592. Famotidine Injection Sales: by Age Group(K Tons)
  • Table 593. Famotidine Injection Sales Pediatric Patients < 1 Year of Age , by Region K Tons (2020-2025)
  • Table 594. Famotidine Injection Sales 1-16 Years of Age , by Region K Tons (2020-2025)
  • Table 595. Famotidine Injection Sales Others , by Region K Tons (2020-2025)
  • Table 596. Famotidine Injection Sales: by Side Effects(K Tons)
  • Table 597. Famotidine Injection Sales Headache , by Region K Tons (2020-2025)
  • Table 598. Famotidine Injection Sales Hives , by Region K Tons (2020-2025)
  • Table 599. Famotidine Injection Sales Rash , by Region K Tons (2020-2025)
  • Table 600. Famotidine Injection Sales Dizziness , by Region K Tons (2020-2025)
  • Table 601. Famotidine Injection Sales Pain , by Region K Tons (2020-2025)
  • Table 602. Famotidine Injection Sales Others , by Region K Tons (2020-2025)
  • Table 603. South America Famotidine Injection Sales, by Country K Tons (2020-2025)
  • Table 604. South America Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 605. South America Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 606. South America Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 607. South America Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 608. South America Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 609. South America Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 610. Brazil Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 611. Brazil Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 612. Brazil Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 613. Brazil Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 614. Brazil Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 615. Brazil Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 616. Argentina Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 617. Argentina Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 618. Argentina Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 619. Argentina Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 620. Argentina Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 621. Argentina Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 622. Rest of South America Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 623. Rest of South America Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 624. Rest of South America Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 625. Rest of South America Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 626. Rest of South America Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 627. Rest of South America Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 628. Asia Pacific Famotidine Injection Sales, by Country K Tons (2020-2025)
  • Table 629. Asia Pacific Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 630. Asia Pacific Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 631. Asia Pacific Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 632. Asia Pacific Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 633. Asia Pacific Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 634. Asia Pacific Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 635. China Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 636. China Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 637. China Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 638. China Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 639. China Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 640. China Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 641. Japan Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 642. Japan Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 643. Japan Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 644. Japan Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 645. Japan Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 646. Japan Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 647. India Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 648. India Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 649. India Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 650. India Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 651. India Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 652. India Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 653. South Korea Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 654. South Korea Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 655. South Korea Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 656. South Korea Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 657. South Korea Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 658. South Korea Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 659. Taiwan Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 660. Taiwan Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 661. Taiwan Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 662. Taiwan Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 663. Taiwan Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 664. Taiwan Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 665. Australia Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 666. Australia Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 667. Australia Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 668. Australia Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 669. Australia Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 670. Australia Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 671. Rest of Asia-Pacific Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 672. Rest of Asia-Pacific Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 673. Rest of Asia-Pacific Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 674. Rest of Asia-Pacific Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 675. Rest of Asia-Pacific Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 676. Rest of Asia-Pacific Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 677. Europe Famotidine Injection Sales, by Country K Tons (2020-2025)
  • Table 678. Europe Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 679. Europe Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 680. Europe Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 681. Europe Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 682. Europe Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 683. Europe Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 684. Germany Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 685. Germany Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 686. Germany Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 687. Germany Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 688. Germany Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 689. Germany Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 690. France Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 691. France Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 692. France Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 693. France Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 694. France Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 695. France Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 696. Italy Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 697. Italy Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 698. Italy Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 699. Italy Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 700. Italy Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 701. Italy Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 702. United Kingdom Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 703. United Kingdom Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 704. United Kingdom Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 705. United Kingdom Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 706. United Kingdom Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 707. United Kingdom Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 708. Netherlands Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 709. Netherlands Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 710. Netherlands Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 711. Netherlands Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 712. Netherlands Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 713. Netherlands Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 714. Rest of Europe Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 715. Rest of Europe Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 716. Rest of Europe Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 717. Rest of Europe Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 718. Rest of Europe Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 719. Rest of Europe Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 720. MEA Famotidine Injection Sales, by Country K Tons (2020-2025)
  • Table 721. MEA Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 722. MEA Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 723. MEA Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 724. MEA Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
  • Table 725. MEA Famotidine Injection Sales, by Age Group K Tons (2020-2025)
  • Table 726. MEA Famotidine Injection Sales, by Side Effects K Tons (2020-2025)
  • Table 727. Middle East Famotidine Injection Sales, by Type K Tons (2020-2025)
  • Table 728. Middle East Famotidine Injection Sales, by Application K Tons (2020-2025)
  • Table 729. Middle East Famotidine Injection Sales, by Components K Tons (2020-2025)
  • Table 730. Middle East Famotidine Injection Sales, by Distribution Channel K Tons (2020-2025)
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Famotidine Injection: by Type USD Million (2014-2019)
  • Figure 5. Global Famotidine Injection: by Application USD Million (2014-2019)
  • Figure 6. Global Famotidine Injection: by Components USD Million (2014-2019)
  • Figure 7. Global Famotidine Injection: by Distribution Channel USD Million (2014-2019)
  • Figure 8. Global Famotidine Injection: by Age Group USD Million (2014-2019)
  • Figure 9. Global Famotidine Injection: by Side Effects USD Million (2014-2019)
  • Figure 10. South America Famotidine Injection Share (%), by Country
  • Figure 11. Asia Pacific Famotidine Injection Share (%), by Country
  • Figure 12. Europe Famotidine Injection Share (%), by Country
  • Figure 13. MEA Famotidine Injection Share (%), by Country
  • Figure 14. North America Famotidine Injection Share (%), by Country
  • Figure 15. Global Famotidine Injection: by Type K Tons (2014-2019)
  • Figure 16. Global Famotidine Injection: by Application K Tons (2014-2019)
  • Figure 17. Global Famotidine Injection: by Components K Tons (2014-2019)
  • Figure 18. Global Famotidine Injection: by Distribution Channel K Tons (2014-2019)
  • Figure 19. Global Famotidine Injection: by Age Group K Tons (2014-2019)
  • Figure 20. Global Famotidine Injection: by Side Effects K Tons (2014-2019)
  • Figure 21. South America Famotidine Injection Share (%), by Country
  • Figure 22. Asia Pacific Famotidine Injection Share (%), by Country
  • Figure 23. Europe Famotidine Injection Share (%), by Country
  • Figure 24. MEA Famotidine Injection Share (%), by Country
  • Figure 25. North America Famotidine Injection Share (%), by Country
  • Figure 26. Global Famotidine Injection: by Type USD/Units (2014-2019)
  • Figure 27. Global Famotidine Injection share by Players 2019 (%)
  • Figure 28. Global Famotidine Injection share by Players (Top 3) 2019(%)
  • Figure 29. BCG Matrix for key Companies
  • Figure 30. Medline Industries (United States) Revenue, Net Income and Gross profit
  • Figure 31. Medline Industries (United States) Revenue: by Geography 2019
  • Figure 32. Allegiance Health (United States) Revenue, Net Income and Gross profit
  • Figure 33. Allegiance Health (United States) Revenue: by Geography 2019
  • Figure 34. Ciron Group (India) Revenue, Net Income and Gross profit
  • Figure 35. Ciron Group (India) Revenue: by Geography 2019
  • Figure 36. CVS Health (United States) Revenue, Net Income and Gross profit
  • Figure 37. CVS Health (United States) Revenue: by Geography 2019
  • Figure 38. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Mylan N.V. (United States) Revenue: by Geography 2019
  • Figure 40. McKesson Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 41. McKesson Pharma (United States) Revenue: by Geography 2019
  • Figure 42. Global Famotidine Injection: by Type USD Million (2020-2025)
  • Figure 43. Global Famotidine Injection: by Application USD Million (2020-2025)
  • Figure 44. Global Famotidine Injection: by Components USD Million (2020-2025)
  • Figure 45. Global Famotidine Injection: by Distribution Channel USD Million (2020-2025)
  • Figure 46. Global Famotidine Injection: by Age Group USD Million (2020-2025)
  • Figure 47. Global Famotidine Injection: by Side Effects USD Million (2020-2025)
  • Figure 48. South America Famotidine Injection Share (%), by Country
  • Figure 49. Asia Pacific Famotidine Injection Share (%), by Country
  • Figure 50. Europe Famotidine Injection Share (%), by Country
  • Figure 51. MEA Famotidine Injection Share (%), by Country
  • Figure 52. North America Famotidine Injection Share (%), by Country
  • Figure 53. Global Famotidine Injection: by Type K Tons (2020-2025)
  • Figure 54. Global Famotidine Injection: by Application K Tons (2020-2025)
  • Figure 55. Global Famotidine Injection: by Components K Tons (2020-2025)
  • Figure 56. Global Famotidine Injection: by Distribution Channel K Tons (2020-2025)
  • Figure 57. Global Famotidine Injection: by Age Group K Tons (2020-2025)
  • Figure 58. Global Famotidine Injection: by Side Effects K Tons (2020-2025)
  • Figure 59. South America Famotidine Injection Share (%), by Country
  • Figure 60. Asia Pacific Famotidine Injection Share (%), by Country
  • Figure 61. Europe Famotidine Injection Share (%), by Country
  • Figure 62. MEA Famotidine Injection Share (%), by Country
  • Figure 63. North America Famotidine Injection Share (%), by Country
  • Figure 64. Global Famotidine Injection: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Medline Industries (United States)
  • Allegiance Health (United States)
  • Ciron Group (India)
  • CVS Health (United States)
  • Mylan N.V. (United States)
  • McKesson Pharma (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation